vs
Immunocore Holdings plc（IMCR）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
Immunocore Holdings plc的季度营收约是REPUBLIC BANCORP INC的1.1倍（$104.5M vs $94.3M），Immunocore Holdings plc同比增速更快（24.3% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $-35.5M），过去两年Immunocore Holdings plc的营收复合增速更高（21.7% vs -11.5%）
Immunocore是一家处于商业化阶段的全球生物技术企业，总部位于英国牛津郡，依托可溶性T细胞受体技术深耕生物药物的研发领域，其创新技术平台为肿瘤、感染性疾病、自身免疫性疾病等多领域的新药开发提供支撑。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
IMCR vs RBCAA — 直观对比
营收规模更大
IMCR
是对方的1.1倍
$94.3M
营收增速更快
IMCR
高出19.0%
5.3%
自由现金流更多
RBCAA
多$196.6M
$-35.5M
两年增速更快
IMCR
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.5M | $94.3M |
| 净利润 | — | $22.8M |
| 毛利率 | 97.4% | — |
| 营业利润率 | -18.8% | 29.3% |
| 净利率 | — | 24.2% |
| 营收同比 | 24.3% | 5.3% |
| 净利润同比 | — | 20.0% |
| 每股收益（稀释后） | $-0.61 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMCRRBCAA
| Q4 25 | $104.5M | $94.3M | ||
| Q3 25 | $103.7M | $93.5M | ||
| Q2 25 | $98.0M | $93.8M | ||
| Q1 25 | $93.9M | $135.8M | ||
| Q4 24 | $84.1M | $89.5M | ||
| Q3 24 | $80.2M | $88.1M | ||
| Q2 24 | $75.4M | $86.9M | ||
| Q1 24 | $70.5M | $120.3M |
净利润IMCRRBCAA
| Q4 25 | — | $22.8M | ||
| Q3 25 | $-177.0K | $29.7M | ||
| Q2 25 | $-10.3M | $31.5M | ||
| Q1 25 | $5.0M | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $8.7M | $26.5M | ||
| Q2 24 | $-11.6M | $25.2M | ||
| Q1 24 | $-24.4M | $30.6M |
毛利率IMCRRBCAA
| Q4 25 | 97.4% | — | ||
| Q3 25 | 99.5% | — | ||
| Q2 25 | 98.9% | — | ||
| Q1 25 | 99.1% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 97.7% | — | ||
| Q1 24 | 99.7% | — |
营业利润率IMCRRBCAA
| Q4 25 | -18.8% | 29.3% | ||
| Q3 25 | -6.9% | 40.4% | ||
| Q2 25 | -15.2% | 43.0% | ||
| Q1 25 | -3.9% | 44.1% | ||
| Q4 24 | -23.1% | 25.8% | ||
| Q3 24 | -10.6% | 38.4% | ||
| Q2 24 | -21.2% | 37.0% | ||
| Q1 24 | -37.6% | 32.2% |
净利率IMCRRBCAA
| Q4 25 | — | 24.2% | ||
| Q3 25 | -0.2% | 31.8% | ||
| Q2 25 | -10.5% | 33.5% | ||
| Q1 25 | 5.4% | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | 10.9% | 30.1% | ||
| Q2 24 | -15.4% | 29.0% | ||
| Q1 24 | -34.7% | 25.4% |
每股收益（稀释后）IMCRRBCAA
| Q4 25 | $-0.61 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $-0.20 | — | ||
| Q1 25 | $0.10 | — | ||
| Q4 24 | $-0.47 | — | ||
| Q3 24 | $0.17 | — | ||
| Q2 24 | $-0.23 | — | ||
| Q1 24 | $-0.49 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $864.2M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $381.0M | $1.1B |
| 总资产 | $1.1B | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMCRRBCAA
| Q4 25 | $864.2M | $220.0M | ||
| Q3 25 | $892.4M | $484.2M | ||
| Q2 25 | $882.8M | $484.8M | ||
| Q1 25 | $837.0M | $793.0M | ||
| Q4 24 | $820.4M | $432.2M | ||
| Q3 24 | $901.3M | $530.9M | ||
| Q2 24 | $859.6M | $400.1M | ||
| Q1 24 | $832.8M | $546.4M |
总债务IMCRRBCAA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $438.7M | — | ||
| Q2 24 | $452.5M | — | ||
| Q1 24 | $452.5M | — |
股东权益IMCRRBCAA
| Q4 25 | $381.0M | $1.1B | ||
| Q3 25 | $396.6M | $1.1B | ||
| Q2 25 | $388.5M | $1.1B | ||
| Q1 25 | $378.5M | $1.0B | ||
| Q4 24 | $360.7M | $992.0M | ||
| Q3 24 | $377.8M | $979.7M | ||
| Q2 24 | $359.1M | $955.4M | ||
| Q1 24 | $359.5M | $935.6M |
总资产IMCRRBCAA
| Q4 25 | $1.1B | $7.0B | ||
| Q3 25 | $1.1B | $7.0B | ||
| Q2 25 | $1.1B | $7.0B | ||
| Q1 25 | $1.0B | $7.1B | ||
| Q4 24 | $1.0B | $6.8B | ||
| Q3 24 | $1.1B | $6.7B | ||
| Q2 24 | $1.0B | $6.6B | ||
| Q1 24 | $994.0M | $6.9B |
负债/权益比IMCRRBCAA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.26× | — | ||
| Q1 24 | 1.26× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.7M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $-35.5M | $161.1M |
| 自由现金流率自由现金流/营收 | -34.0% | 170.9% |
| 资本支出强度资本支出/营收 | 2.8% | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | $-15.1M | $288.6M |
8季度趋势，按日历期对齐
经营现金流IMCRRBCAA
| Q4 25 | $-32.7M | $168.2M | ||
| Q3 25 | $-4.5M | $33.3M | ||
| Q2 25 | $26.0M | $8.4M | ||
| Q1 25 | $435.0K | $93.2M | ||
| Q4 24 | $-14.0M | $149.0M | ||
| Q3 24 | $21.1M | $51.3M | ||
| Q2 24 | $23.5M | $4.0M | ||
| Q1 24 | $-4.6M | $71.2M |
自由现金流IMCRRBCAA
| Q4 25 | $-35.5M | $161.1M | ||
| Q3 25 | $-5.2M | $30.8M | ||
| Q2 25 | $25.6M | $5.2M | ||
| Q1 25 | $137.0K | $91.6M | ||
| Q4 24 | $-17.5M | $143.2M | ||
| Q3 24 | $20.3M | $49.8M | ||
| Q2 24 | $23.1M | $2.7M | ||
| Q1 24 | $-5.0M | $69.1M |
自由现金流率IMCRRBCAA
| Q4 25 | -34.0% | 170.9% | ||
| Q3 25 | -5.0% | 32.9% | ||
| Q2 25 | 26.1% | 5.5% | ||
| Q1 25 | 0.1% | 67.4% | ||
| Q4 24 | -20.9% | 160.0% | ||
| Q3 24 | 25.3% | 56.5% | ||
| Q2 24 | 30.7% | 3.1% | ||
| Q1 24 | -7.1% | 57.5% |
资本支出强度IMCRRBCAA
| Q4 25 | 2.8% | 7.5% | ||
| Q3 25 | 0.7% | 2.6% | ||
| Q2 25 | 0.4% | 3.5% | ||
| Q1 25 | 0.3% | 1.2% | ||
| Q4 24 | 4.3% | 6.5% | ||
| Q3 24 | 1.0% | 1.7% | ||
| Q2 24 | 0.4% | 1.5% | ||
| Q1 24 | 0.6% | 1.7% |
现金转化率IMCRRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | 0.09× | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | 2.42× | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
